Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leucine-rich repeat-containing protein 15 (LRRC15) is a cell membrane-expressed protein involved in cell-cell and cell-extracellular matrix interactions. It contains 15 leucine-rich repeats (LRRs) in its extracellular region, a transmembrane domain, and a short intracellular tail. LRRC15 is expressed in tissues such as the placenta, skin, activated fibroblasts in wounds, and lymphoid tissues. It binds fibronectin, laminin, and collagen, suggesting a role in cell adhesion. LRRC15 also interacts with the SARS-CoV-2 spike protein, inhibiting viral entry and inducing antiviral transcriptional programs. Aberrant expression has been observed in cancer-associated fibroblasts and some mesenchymal tumors.
Modulates cell adhesion and signaling through interaction with ECM components and viral proteins; influences antiviral transcriptional programs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leucine-rich repeat-containing protein 15 (None).